Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 5.
Figure 5.

The (dCas9/sgFabp4) + ATS-9R oligoplexes ameliorate inflammation and hepatic steatosis in obese mice. Data are presented as relative mRNA levels in (A) epiWAT Fabp4, (B) subWAT Fabp4, (C) epiWAT cytokines, and (D) subWAT cytokines. Serum levels of (E) FFA, (F) TG, (G) ALT, and (H) AST. (I) Representative hematoxylin and eosin sections of liver tissue. Error bars indicate SEM (n = 5) and scale bar = 100 µm. Significance was computed by analysis of variance and Bonferroni's post hoc test in comparison to control groups. (*) P < 0.05, (**) P < 0.001, (***) P < 0.001 was considered significant.

This Article

  1. Genome Res. 29: 1442-1452

Preprint Server